Dwight H. Owen

Non–Small Cell Lung Cancer, Version 4.2024

Gregory J. Riely, Douglas E. Wood, David S. Ettinger et al. · Journal of the National Comprehensive Cancer Network · 2024 · 756 citations

Medicine, Molecular Medicine, Oncology +15

Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer

Bairavi Shankar, Jiajia Zhang, Abdul Rafeh Naqash et al. · JAMA Oncology · 2020 · 489 citations · Full text

Medicine, Immunology, Oncology +17

Targeting RET in Patients With <i>RET</i>-Rearranged Lung Cancers: Results From the Global, Multicenter <i>RET</i> Registry

Oliver Gautschi, Julie Milia, Thomas Filleron et al. · Journal of Clinical Oncology · 2017 · 356 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

Jamie E. Chaft, Filiz Öezkan, Mark G. Kris et al. · Nature Medicine · 2022 · 237 citations · Full text

Medicine, Oncology, Pharmacology +17

Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET–Rearranged Lung Cancers

Alexander Drilon, Thomas Filleron, Ai Ni et al. · Journal of Thoracic Oncology · 2018 · 231 citations

Medicine, Oncology, Metastasis +16